A First Look at Phase 2 ArMaDa Data - Poll - MDSpire

A First Look at Phase 2 ArMaDa Data

Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

  • By

  • Arshad M. Khanani, MD, MA, FASRS

  • July 15, 2026

  • 2 min

Share

Original Source(s)

A First Look at Phase 2 ArMaDa Data

  • by Arshad M. Khanani, MD, MA, FASRS

  • July 15, 2026

Related Content

OTX-TKI: Inside the SOL-1 Data

At ASRS 2026, Dilsher S. Dhoot, MD, FASRS, shared additional phase 3 SOL-1 data on vision maintenance, rescue treatment, and safety with investigational OTX-TKI (Axpaxli) in neovascular AMD.

"Landmark" Dataset Maps Anterior Segment Disease

Moorfields and UCL launch dataset aiming to accelerate research into anterior segment conditions

  • July 16, 2026

  • 2 min
Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities